# A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

Study · id `cardio:ct-nct07306182` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07306182](<https://clinicaltrials.gov/study/NCT07306182>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07306182

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

## Technical summary

Registry record NCT07306182. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-09 (actual); primary completion 2027-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT07306182, source copy `cardio:ctgov-nct07306182-2026-07-13`, retrieved 2026-10-26)
- Started: 2026-03-09 (actual) (ClinicalTrials.gov record NCT07306182, source copy `cardio:ctgov-nct07306182-2026-07-13`, retrieved 2026-10-26)
- Primary completion: 2027-04 (anticipated) (ClinicalTrials.gov record NCT07306182, source copy `cardio:ctgov-nct07306182-2026-07-13`, retrieved 2026-10-26)
- Completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT07306182, source copy `cardio:ctgov-nct07306182-2026-07-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07306182, source copy `cardio:ctgov-nct07306182-2026-07-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07306182-2026-07-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction
- Condition: Acute Anterior ST-Segment Elevation Myocardial Infarction
- Intervention (Drug): SGC001 injection
- Intervention (Drug): SGC001 injection
- Intervention (Drug): Placebo
- Lead sponsor: Beijing Sungen Biomedical Technology Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: 140347776ea336f3b0c49f5cb8ed249d57be220d3ab6a8047b9e6737b8c0c24d
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
